Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
mRNA-1273 SARS-CoV-2-vaccin 94,1% werkzaam
feb 2021 | Vaccinatie, Virale infecties